BHAT vs MPU

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 3/9, indicating poor operational and balance sheet strength. Despite a remarkably high current ratio of 23.03 and low debt/equity of 0.04, the company is deeply unprofitable, with a profit margin of -47.88% and ROE of -14.99%, severely undermining its valuation. Revenue growth is negligible at 1.90% YoY, while the stock has lost nearly all value over the past five years (-99.9%), and trading metrics are largely unavailable due to financial opacity. Compared to sector peers, BHAT lags in growth, profitability, and market confidence, with no analyst coverage or target prices, reinforcing a high-risk profile.

MPU exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is suffering from a massive revenue collapse (-49.20% YoY) and extreme operational inefficiency with an operating margin of -376.36%. While the current ratio of 4.06 suggests short-term liquidity, the combination of a 0/100 technical trend and consistent earnings misses points to a failing business model. The stock is in a long-term structural decline, losing over 72% of its value over the last five years.